Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial
Omiganan is an indolicidin analog with antimicrobial properties that could be beneficial for patients with atopic dermatitis. In this randomized, double‐blind, placebo‐controlled, phase II trial we explored the efficacy, pharmacodynamics, and safety of topical omiganan once daily in 36 patients with...
Saved in:
Main Authors: | Tessa Niemeyer‐van der Kolk (Author), Hein van derWall (Author), Geretta K. Hogendoorn (Author), Rianne Rijneveld (Author), Sascha Luijten (Author), Dirk C.J.G. vanAlewijk (Author), Ellen H.A. van denMunckhof (Author), Marieke L. deKam (Author), Gary L. Feiss (Author), Errol P. Prens (Author), Jacobus Burggraaf (Author), Robert Rissmann (Author), Martijn B.A. vanDoorn (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers
by: Tessa Niemeyer‐van der Kolk, et al.
Published: (2020) -
Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis
by: Ellen H.A. van den Munckhof, et al.
Published: (2020) -
Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
by: Hendrika W. Grievink, et al.
Published: (2020) -
Chapter 11 Liminal Precarity and Compromised Agency Migrant experiences of gig work in Amsterdam, Berlin, and New York City
by: van Doorn, Niels
Published: (2023) -
Chapter 6: Dual value production as key to the gig economy puzzle
by: van Doorn, Niels
Published: (2021)